Current location:home page > Food Technology

Givaudan sees 5.7% like-for-like sales increase

In the first three months of 2014 Givaudan recorded sales of CHF1,087 million, an increase of 5.7% o…
In the first three months of 2014 Givaudan recorded sales of CHF1,087 million, an increase of 5.7% on a like-for-like basis, and a decline of 0.2% in Swiss francs compared to the previous year. Flavour sales were CHF 571.2 million, up 5.8% on a like-for-like basis. Like-for-like excludes the impact of currency, acquisitions and disposals.

Givaudan said that it started the year with a strong business momentum, a full project pipeline and win rates sustained at a high level. Like-for-like growth rates were in line with the company’s mid-term sales growth objectives. Sales in developing markets increased by 9.8% on a like-for-like basis.

Mid-term, Givaudan said that the overall objective is to grow organically between 4.5% and 5.5% per annum, assuming a market growth of 2-3%, and to continue on the path of market share gains. By delivering on the company's five-pillar growth strategy – developing markets, health and wellness, market share gains with targeted customers and segments, research and sustainable sourcing – Givaudan said that it expects to outgrow the underlying market and to continue to achieve its industry-leading EBITDA margin.

In the Flavours division, sales increased in the developing markets of Africa, China, Eastern Europe, India and Indonesia as a result of existing business growth and new wins. Strong growth continued in Latin America driven by key markets while the mature markets of Asia and Europe showed good resiliency in delivering positive year-on-year growth. Growth was achieved across all segments with particular strength in beverages, dairy, and snacks.

Sales for Asia Pacific increased 10.5% on a like-for-like basis. The developing markets of China, India, Indonesia and Vietnam reported strong double-digit growth. The mature markets of Korea, Oceania and Singapore were above prior year. All major business segments achieved solid growth driven by a steady inflow of new wins and organic growth of existing business.

Sales in Europe, Africa and the Middle East grew 3.5% on a like-for-like basis. The developing markets delivered good growth when compared to the prior year. The mature markets of Western, Central and Northern Europe reported a moderate growth. The overall increase was driven by beverages and dairy.

Latin America experienced double-digit growth of 15.4% on a like-for-like basis, continuing on the success of the previous year. Increases in the largest markets of Argentina and Brazil led the way. New wins and growth of existing products in beverages, dairy and snacks leveraged the sales performance.

Sales increased by 0.2% on a like-for-like basis in North America. Strong double-digit growth in Snacks coupled with good gains achieved in dairy and sweet goods were offset by weakness in the savoury and beverage segments as result of unfavourable market conditions.

Related articles

PepsiCo bottle does not infringe Coke ‘Contour' trademarks – German court

The Hamburg Regional Court said – in a verdict delivered on May 31 in the case LG Hamburg 315 O 310/…

New Tropicana Pure Premium PET clear container 'unique' in juice aisle

Michael Torres, spokesman for the PepsiCo owned brand, said that the new multi-serve 89oz (2.6 litre…

2013 International Production & Processing Expo (IPPE)

2013 International Production & Processing Expo (IPPE)

The 2013 International Production & Processing Expo (IPPE) has set a record with over 1,150 exhi…

Wine label printer Tapp buys Ben Franklin Press & Label

Tapp Label Technologies (TLT), a manufacturer of pressure sensitive labels for wine and spirits indu…

Researchers unlock key components of wheat's genetic code

Researchers unlock key components of wheat's genetic code

Scientists from the UK, Germany and the US have identified key parts of the genetic code of wheat, a…

Country's 'plant clinics' aid farmers without chemicals

A room with a microscope, networked computer and drugs appears at first glance to be in a hospital.…